O ORZELIA Trademark

Trademark Overview


On Thursday, March 14, 2024, a trademark application was filed for O ORZELIA with the United States Patent and Trademark Office. The USPTO has given the O ORZELIA trademark a serial number of 98449745. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 29, 2024. This trademark is owned by GLAXO GROUP LIMITED. The O ORZELIA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, and psychiatric related diseases and disorders; all of the foregoing excluding pharmaceutical preparations for the treatment of auto-immune diseases or rheumatoid arthritis
o orzelia

General Information


Serial Number98449745
Word MarkO ORZELIA
Filing DateThursday, March 14, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 29, 2024

Trademark Statements


Description of MarkThe mark consists of two overlapping geometric shapes resembling the letter "O", with the word ORZELIA in stylized lettering to the right of the O design.
Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, and psychiatric related diseases and disorders; all of the foregoing excluding pharmaceutical preparations for the treatment of auto-immune diseases or rheumatoid arthritis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGLAXO GROUP LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGLAXO GROUP LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Thursday, March 14, 2024NEW APPLICATION ENTERED
Saturday, June 8, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, June 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 18, 2024ASSIGNED TO EXAMINER
Friday, September 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 29, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED